{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:25:43Z","timestamp":1777969543059,"version":"3.51.4"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T00:00:00Z","timestamp":1394064000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090929","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T21:56:50Z","timestamp":1394143010000},"page":"e90929","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Comparing Staging Systems for Predicting Prognosis and Survival in Patients with Hepatocellular Carcinoma in Egypt"],"prefix":"10.1371","volume":"9","author":[{"given":"Asmaa Ibrahim","family":"Gomaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Saad","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imam","family":"Waked","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Current concepts Hepatocellular carcinoma: review","volume":"365","author":"HB El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"ref2","first-page":"2893","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int","volume":"127","author":"J Ferlay","year":"2010","journal-title":"J. Cancer"},{"key":"ref3","unstructured":"GLOBOCAN 2008 v1.2, Cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide: IARC: International Agency for Research on Cancer; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/globocan.iarc.fr\" xlink:type=\"simple\">http:\/\/globocan.iarc.fr<\/ext-link>.Accessed 2013 Nov 13."},{"key":"ref4","first-page":"5193","article-title":"Hepatocellular carcinoma in Egypt: A single center study over a decade. World J Gastroenterol","volume":"11","author":"AR El-Zayadi","year":"2005"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Marrero JA, Kudo M, Bronowicki J (2010) The Challenge of Prognosis and Staging for Hepatocellular Carcinoma. Oncologist (suppl 4): 23\u201333.","DOI":"10.1634\/theoncologist.2010-S4-23"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gut.2004.048124","article-title":"Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre","volume":"54","author":"A Grieco","year":"2005","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"K Okuda","year":"1985","journal-title":"Cancer"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jamcollsurg.2006.06.030","article-title":"Prognostic Value and Clinical Relevance of the 6th Edition 2002 American Joint Committee on Cancer Staging System in Patients with Resectable Hepatocellular Carcinoma","volume":"203","author":"HJ Lei","year":"2006","journal-title":"J Am Coll Surg"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","article-title":"A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients","volume":"28","author":"G Manghisi","year":"1998","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma","volume":"31","author":"S Chevret","year":"1999","journal-title":"J Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"JM Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/gut.48.1.103","article-title":"Hepatocellular carcinoma in Central Europe: prognostic features and survival","volume":"48","author":"M Schoniger-Hekele","year":"2001","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"TW Leung","year":"2002","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s005350300038","article-title":"Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging score (JIS score)","volume":"38","author":"M Kudo","year":"2003","journal-title":"J Gastroenterol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/gut.2003.035055","article-title":"Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients","volume":"54","author":"R Tateishi","year":"2005","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2005.12.015","article-title":"Prospective validation of the Barcelona Clinic Liver Cancer staging system","volume":"44","author":"U Cillo","year":"2006","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jhep.2003.09.027","article-title":"The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?","volume":"40","author":"U Cillo","year":"2004","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejso.2005.04.016","article-title":"Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis","volume":"31","author":"A Nanashima","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1440-1746.2005.03746.x","article-title":"Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery","volume":"20","author":"YH Huang","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/bjs.4554","article-title":"Critical evaluation of the different staging systems for hepatocellular carcinoma","volume":"91","author":"S Wildi","year":"2004","journal-title":"Br J Surg"},{"key":"ref21","first-page":"e104","article-title":"Prognostic Factors for Hepatocellular Carcinoma: Is it ready for Primetime?","volume":"2","author":"J Wu","year":"2013","journal-title":"J Liver"},{"key":"ref22","first-page":"20","article-title":"Staging Systems for Hepatocellular Carcinoma","volume":"18","author":"H Zhang","year":"2013","journal-title":"Journal of tumor"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/1097-0142(20001201)89:11<2266::AID-CNCR15>3.0.CO;2-0","article-title":"How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system","volume":"89","author":"F Farinati","year":"2000","journal-title":"Cancer"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.20636","article-title":"Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort","volume":"41","author":"JA Marrero","year":"2005","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"AASLD Practice Guidlines. Management of Hepatocellular Carcinoma","volume":"42","author":"J Bruix","year":"2005","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"E Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"DR Cox","year":"1974","journal-title":"J R Stat Soc"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/jhep.2001.27219","article-title":"Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients","volume":"34","author":"S Ueno","year":"2001","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143(1)","author":"JA Hanley","year":"1982","journal-title":"Radiology"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Qin LX, Tang ZY (2002) The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol. 8: 385\u2013392. Review.","DOI":"10.3748\/wjg.v8.i3.385"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1478-3231.2006.01282.x","article-title":"Comparison of staging systems to predict survival in hepatocellular carcinoma","volume":"26","author":"S Pascual","year":"2006","journal-title":"Liver International"},{"key":"ref32","first-page":"112","article-title":"Postoperative detection of AFP mRNA in the peripheral blood of hepatic cellular carcinoma patients and its correlation with recurrence. Zhonghua Zhong Liu Za Zhi","volume":"29","author":"H Zhi","year":"2007"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1478-3231.2006.001285.x","article-title":"Treatment and prognostic factors in patients with hepatocellular carcinoma","volume":"26","author":"A Martins","year":"2006","journal-title":"Liver International"},{"key":"ref34","first-page":"4465","article-title":"Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma. World J Gastroenterol","volume":"11","author":"MS Liem","year":"2005"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/ijc.20279","article-title":"High \u03b1-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and \u03b2-catenin mutations","volume":"112","author":"SY Peng","year":"2004","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"JM Llovet","year":"2003","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-5876-5-3","article-title":"Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma","volume":"5","author":"F Grizzi","year":"2007","journal-title":"J Transl Med"},{"key":"ref38","first-page":"17","article-title":"Prognostic factors for survival in patients with hepatocellular carcinoma after radiofrequency ablation","volume":"49","author":"JH Lee","year":"2007","journal-title":"Korean J Gastroenterol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3748\/wjg.v13.i7.1003","article-title":"Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma","volume":"13","author":"M Morimoto","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.coc.0000136019.94333.09","article-title":"Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis","volume":"27","author":"B Sakar","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.crad.2005.04.009","article-title":"Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients","volume":"60","author":"HX Xu","year":"2005","journal-title":"Clin Radiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3350\/kjhep.2008.14.3.371","article-title":"Risk factors for early recurrence after surgical resection for hepatocellular carcinoma","volume":"14","author":"UJ Park","year":"2008","journal-title":"Korean J Hepatol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.50.6.881","article-title":"Assessment of the CLIP, Okuda, and Child\u2013Pugh staging systems in a cohort of 257 patients in Toronto","volume":"50","author":"I Levy","year":"2002","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cncr.23185","article-title":"Comparison of 7 Staging Systems for Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization","volume":"112","author":"Y Cho","year":"2008","journal-title":"Cancer"},{"key":"ref45","first-page":"1117","article-title":"Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials. Ann","volume":"19","author":"S Collette","year":"2008","journal-title":"Oncol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1572-0241.2007.01604.x","article-title":"Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response","volume":"103","author":"A Guglielmi","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref47","first-page":"1534","article-title":"Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma","volume":"54","author":"K Kondo","year":"2007","journal-title":"Hepatogasteroenterology"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Huo T, Huang YH, Lee SD, Wu JC (2005) Is there an ideal prognostic model for hepatocellular carcinoma. Gut 54; 1348.","DOI":"10.1136\/gut.2005.069468"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1200\/JCO.2009.25.9895","article-title":"Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?","volume":"28","author":"FD Huitzil-Melendez","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref50","first-page":"431","article-title":"A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients. Dig Liver Dis","volume":"41","author":"YH Yen","year":"2009"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.20486","article-title":"Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: the JIS Score Compared With the CLIP Score","volume":"40","author":"M Kudo","year":"2004","journal-title":"Hepatology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/j.1572-0241.2005.41943.x","article-title":"Comparison of the usefulness of 3 staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan","volume":"100","author":"H Toyoda","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Kudo M, Okanoue T, Japan Society of Hepatology (2007) Management of hepatocellular carcinoma in Japan: consensus based clinical practice manual proposed by the Japan Society of Hepatology. Oncology (suppl 1): 2\u201315.","DOI":"10.1159\/000111702"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ejca.2008.12.025","article-title":"Applicability of staging systems for patients with hepatocellular carcinoma depends on treatment method - Analysis of 2010 Taiwanese patients","volume":"45","author":"CH Chen","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/ijc.22616","article-title":"Validation of clinical AJCC\/UICC TNM staging system for hepatocellular carcinoma: Analysis of 5,613 cases from a medical center in southern Taiwan","volume":"120","author":"KM Kee","year":"2007","journal-title":"Int J Cancer"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1386-6346(02)00144-4","article-title":"Prognostic performance of the new classification of primary liver cancer of Japan (4th edition) for patients with hepatocellular carcinoma: a validation analysis","volume":"24","author":"Sh Ueno","year":"2002","journal-title":"Hepatol Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1572-0241.2006.00462.x","article-title":"Proposal of a modified cancer of the liver Italian program staging system based on the model for end-stage liver disease for patients with hepatocellular carcinoma undergoing loco-regional therapy","volume":"101","author":"TI Huo","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e45066","DOI":"10.1371\/journal.pone.0045066","article-title":"Prognosis of Patients with Hepatocellular Carcinoma. Validation and Ranking of Established Staging-Systems in a Large Western HCC-Cohort","volume":"7","author":"M op den Winkel","year":"2012","journal-title":"PLOS ONE"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000218345","article-title":"Clinical Staging of Hepatocellular Carcinoma","volume":"27","author":"V Meier","year":"2009","journal-title":"Dig Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T21:19:18Z","timestamp":1716585558000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090929"}},"subtitle":[],"editor":[{"given":"Ferruccio","family":"Bonino","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,6]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090929","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,6]]}}}